Latest Articles

Publication Date
GSK reports promising early results in ovarian and womb cancer drug trial - The Guardian

GSK reports promising early results in ovarian and womb cancer drug trial The Guardian

Published: April 12, 2026, 10:52 p.m.
SYS6043 Shows Initial Antitumor Activity in Pretreated Ovarian, Endometrial, and Cervical Cancer - OncLive

SYS6043 Shows Initial Antitumor Activity in Pretreated Ovarian, Endometrial, and Cervical Cancer OncLive

Published: April 12, 2026, 9:35 p.m.
AR tech prepares patients for endometriosis surgery - AOL.com

AR tech prepares patients for endometriosis surgery AOL.com

Published: April 12, 2026, 9:16 p.m.
EDGE FOCUS: Patriots MOCK DRAFT FEATURES Prioritizing Edge | Day 2 SWING! - newscentermaine.com

EDGE FOCUS: Patriots MOCK DRAFT FEATURES Prioritizing Edge | Day 2 SWING! newscentermaine.com

Published: April 12, 2026, 9:06 p.m.
Efficacy of Pamirtecan in HER2-Expressing Endometrial Cancer - OncLive

Efficacy of Pamirtecan in HER2-Expressing Endometrial Cancer OncLive

Published: April 12, 2026, 9:01 p.m.
Dr Pothuri on Preliminary Data With Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - OncLive

Dr Pothuri on Preliminary Data With Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer OncLive

Published: April 12, 2026, 9 p.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - KELO-AM

GSK sees blockbuster potential in targeted cancer therapy after promising early data KELO-AM

Published: April 12, 2026, 8:44 p.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - KFGO

GSK sees blockbuster potential in targeted cancer therapy after promising early data KFGO

Published: April 12, 2026, 8:44 p.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - WKZO

GSK sees blockbuster potential in targeted cancer therapy after promising early data WKZO

Published: April 12, 2026, 8:44 p.m.
GSK sees blockbuster potential in targeted cancer therapy after promising early data - WSAU

GSK sees blockbuster potential in targeted cancer therapy after promising early data WSAU

Published: April 12, 2026, 8:44 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!